Next Article in Journal
Conjugation of Inulin Improves Anti-Biofilm Activity of Chitosan
Next Article in Special Issue
The Maxi-K (BK) Channel Antagonist Penitrem A as a Novel Breast Cancer-Targeted Therapeutic
Previous Article in Journal
Water-Soluble Fish Protein Intake Led to Lower Serum and Liver Cholesterol Concentrations in Obese Zucker fa/fa Rats
Previous Article in Special Issue
Bis-Indolyl Benzenoids, Hydroxypyrrolidine Derivatives and Other Constituents from Cultures of the Marine Sponge-Associated Fungus Aspergillus candidus KUFA0062
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Two New Terpenoids from Talaromyces purpurogenus

Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
*
Authors to whom correspondence should be addressed.
Mar. Drugs 2018, 16(5), 150; https://doi.org/10.3390/md16050150
Submission received: 30 March 2018 / Revised: 23 April 2018 / Accepted: 27 April 2018 / Published: 2 May 2018

Abstract

:
A new sesquiterpenoid 9,10-diolhinokiic acid (1) and a new diterpenoid roussoellol C (2), together with 4 known compounds, were isolated from the extracts of laboratory cultures of marine-derived fungus Talaromyces purpurogenus. 9,10-diolhinokiic acid is the first thujopsene-type sesquiterpenoid containing a 9,10-diol moiety, and roussoellol C possesses a novel tetracyclic fusicoccane framework with an unexpected hydroxyl at C-4. These new structures were confirmed by spectroscopic data, chemical method, NMR data calculations and electronic circular dichroism (ECD) calculations. The selected compounds were evaluated for cytotoxicities against five human cancer cell lines, including SW480, HL-60, A549, MCF-7, and SMMC-7721 and the IC50 values of compound 2 against MCF-7 and 3 against HL-60 cells were 6.5 and 7.9 μM, respectively.

Graphical Abstract

1. Introduction

Over the past forty years, more than 60% small molecule new drugs have been directly or indirectly derived from natural product source, which demonstrates that natural products continue to play a significant role in drug discovery and development process [1]. Fungi-derived natural products are rich sources of medicines due to their diverse chemical structures and bioactivities. For example, lovastatin, penicillin, echinocandin B, and cyclosporine A have been clinically used as effective medicines, illustrating the significance of fungi-derived metabolites in drug discovery [2].
The fungus Talaromyces purpurogenus, previously known as Penicillium purpurogenum [3], is widely distributed in terrestrial plants, soil, and marine habitats, and has been reported to produce various secondary metabolites such as meroterpenoids [4,5], polyketides [6,7,8,9,10], lipopeptides [10], and sterols [11]. Meanwhile, the impressive structurally diverse metabolites from this fungus exhibit extensive bioactivities including anti-inflammatory [11], anti-influenza virus [7], insecticidal [4], antitumor [9], and antifungal activities [8]. In our screening of extracts of several fungi for their cytotoxic activities, EtOAc extract of T. purpurogenus, isolated from a mud sample, showed significant cytotoxic activity in vitro. A chemical investigation of the fungus T. purpurogenus resulted in the isolation of two new secondary metabolites 9,10-diolhinokiic acid (1) and roussoellol C (2), and four known compounds including dankasterone (3) [12,13], cyclotryprostatin E (4) [14], 6-methoxyspirotryprostatin B (5) [15], and (3S,12aS)-3-methyl-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dion (6) (Figure 1) [16]. Details of isolation, structural elucidation, and cytotoxic activities are presented here.

2. Results and Discussion

2.1. Chemical Identification of Isolated Terpenoids

Compound 1 was isolated as pale yellow oil. The molecular formula of C15H22O4, containing 5 degrees of unsaturation, was deduced from its HRESIMS spectrum (m/z 265.1450 [M − H]; calcd. for C15H21O4, 265.1440). The IR spectrum gave a hydroxyl absorption band at 3432 cm−1 and unsaturated carboxyl and double bond absorbances at 1696 and 1647 cm−1, respectively. The 1H NMR data (Table 1) of 1 showed the existence of one olefinic proton at δH 6.56 (1H, dd, J = 7.0, 1.8 Hz); two oxygenated protons at δH 3.23 (1H, d, J = 3.8 Hz) and 4.03 (1H, ddd, J = 3.8, 3.7, 3.1 Hz); three methyl signals at δH 1.44, 1.31, and 0.78. The 13C NMR and DEPT data (Table 1) showed only 13 carbon resonances, comprising one olefinic carbon [δC 133.7 (C-5)], three methyls [δC 30.6 (C-13), 25.9 (C-14), and 23.5 (C-15)], three methylenes [δC 11.3 (C-2), 42.8 (C-6), and 41.5 (C-8)], three methines including two oxygenated carbons [δC 17.9 (C-3), 72.8 (C-9), and 78.6 (C-10)], as well as three quaternary carbons [δC 35.7 (C-1), 31.9 (C-7), and 39.9 (C-11)]. The missing carbons in the 13C NMR including a carboxyl (δC 171.2) and an olefinic carbon (δC 134.3) were revealed by cross-peaks in the HMBC spectrum. These data indicated compound 1 to be a sesquiterpenoid.
Exhaustive analyses of the 2D NMR spectra of 1 revealed some similarity to (+)-thujopsene [17], a sesquiterpenoid derivative isolated from the liverwort Marchantia polymorpha. However, two oxygenated methines (δH 4.03, δC 72.8 and δH 3.23, δC 78.6) of 1 replaced the methylenes of (+)-thujopsene and one methyl was oxidized to a carboxyl (δC 171.2) group. The presence of a 9,10-diol moiety was demonstrated by the 1H–1H COSY cross-peak of H-9 and H-10, and HMBC correlations from H-9 to C-7 and C-11 and from H-10 to C-8 and C-11. The carboxyl was located at C-4, which was substantiated by the HMBC cross-peaks from H-3 and H-5 to C-12 (Figure 2). Therefore, the planar structure of 1 was identified as a 9, 10-diolhinokiic acid [18]. In the NOESY experiment (Figure 2), the correlations of H-2/Me-15 and H-2/Me-13 suggested that these groups were co-facial and assigned as α-oriented, while, the interactions of H-3/Me-14 and Me-14/H-10 indicated that they were on the opposite face of the ring system and β-oriented. The hydroxyls at C-9 and C-10 were on the same side according to the coupling constant between H-9 and H-10 (J = 3.8 Hz). Thus, the relative configuration of 1 was determined. The absolute stereochemistry of the 9,10-diol moiety in 1 was verified by observing the induced electronic circular dichroism (IECD) spectrum after the addition of dimolybdenum tetraacetate in anhydrous DMSO [19,20]. The obvious negative Cotton effect at 310 nm in the IECD spectrum (Figure 3) permitted the 9R,10S configuration assignment of 1. Combining with the relative configuration, the absolute stereochemistry of 1 was elucidated as 1R,3R,7R,9R,10S (Figure 1).
Compound 2 was isolated as colorless oil that gave a [M + Na]+ ion peak in the HRESIMS spectrum at m/z 371.1839 Δm (calcd. for C20H28O5Na, 371.1834) appropriate for a molecular formula of C20H28O5, corresponding to 7 degrees of unsaturation. The IR spectrum showed a hydroxyl (3430 cm−1) and an ester or lactone carbonyl (1742 cm−1). The 1H NMR data (Table 1) of 2 revealed two olefinic protons at δH 7.04 (1H, m) and 5.31 (1H, s); three oxygenated protons at δH 3.81 (1H, d, J = 4.4 Hz), 3.66 (1H, dd, J = 10.6, 5.3 Hz), and 3.37 (1H, dd, J = 10.6, 7.9 Hz); three methyl signals at δH 0.84 (3H, s), 0.93 (3H, d, J = 7.4 Hz), and 1.04 (3H, d, J = 6.8 Hz). The 13C NMR and DEPT spectra (Table 1) displayed resonances for 20 carbon signals categorized as one carbonyl carbon [δC 173.0 (C-17)], four olefinic carbons [δC 130.5 (C-7), 141.6 (C-8), 122.1 (C-13), and 148.4 (C-14)], one sp3 quaternary carbon [δC 46.9 (C-11)], one hemiketal carbon [δC 114.1 (C-1)], six methines including one oxygenated carbon [δC 41.2 (C-2), 40.8 (C-3), 80.0 (C-4), 52.8 (C-6), 47.9 (C-10), and 36.7 (C-15)], four methylenes including one oxygenated carbon [δC 37.6 (C-1), 26.8 (C-9), 45.5 (C-12), and 67.0 (C-20)], and three methyls [δC 11.0 (C-16), 24.9 (C-18), and 17.7 (C-19)]. Consideration of these data and analyses of the 1H–1H COSY and HMBC spectra (Figure 2) of 2 suggested existence of tetracyclic fusicoccane framework which was similar with that of roussoellol B [21]. Further analyses of the 2D NMR spectra indicated that the methylene at C-4 in roussoellos B was oxygenated (δC 80.0), which was confirmed by 1H–1H COSY cross-peak of H-3 and H-4 and the HBMC correlations from H-4 to C-3, C-5, C-6, and C-16. In addition, the Δ10,14-double bond in roussoello B shifted to C-13 and C-14 which was evidenced by the HBMC correlations from H-13 to C-10, C-11, and C-12. Moreover, HMBC correlations from H-15 and H-19 to the oxygenated methylene carbon at δC 67.0 (C-20) indicated the presence of a hydroxymethyl functionality. Hence, the planar structure of 2 was established as shown.
In the NOESY experiment (Figure 2), the NOESY correlations of H-2/H-10, H-6/H-10, and H-10/Me-19 indicated the β-orientation for these protons. Meanwhile, correlations of H-1/Me-16, Me-16/H-4, and Me-18/H-9 suggested that H-4, Me-16, and Me-18 were on the opposite side and α-oriented. Even though the NOESY correlation of H-10/Me-19 were observed, but the configuration of C-15 could not be determined by the NOESY experiment due to the freely rotation of the bond between C-14 and C-15. In order to determine the relative configuration of 5-OH, the theoretical calculation of 13C NMR chemical shifts of epimers 2a and 2b (Figure 4) were performed to semiempirical PM3 quantum mechanical geometry optimizations using Gaussian09 at the B3LYP/6-31G* level [22]. The experimental shifts were plotted against the calculated shifts, and least-squares fit lines was confirmed. The calculated shifts for 2a and 2b were corrected by the slope and intercept to get the corrected 13C shifts (Table 1), and the differences between the corrected and experimental 13C NMR chemical shifts were analyzed [23,24]. The result showed that the correlation coefficient R2 of 2a (0.9966) was higher than that of 2b (0.9926) (Figures S21 and S22). Meanwhile, the MAE (mean absolute error) and MD (maximum deviation) of 2a (MAE = 2.28, MD = 6.5) were obviously lower than that of 2b (MAE = 2.74, MD = 14.3), suggesting that 2a was more consistent with the experimental values (Figure 4). What’s more, all of the reported fusicoccanes or ophiobolins with 5/8/5/5 ring system possess a cis-fused A/D ring [21,25,26,27,28], and the 5-OH of 2 was finally assigned a β-orientation as 2a.
To determine the absolute configuration of compound 2, the electronic circular dichroism (ECD) calculation was performed. The experimental and simulated spectra generated by BALLOON [29,30] were performed to semiempirical PM3 quantum mechanical geometry optimizations using the Gaussian 09 program (Figures S2 and S3, Supplementary Materials) [31]. The ECD spectrum of each conformer was calculated using the TDDFT methodology at B3LYP/6-311++G(d,p)//B3LYP/6-31G(d) level. Comparison of the experimental and calculated spectra of 2 showed more agreement (Figure 5) for the 2a configuration. The experimental ECD is consistent with the calculated ECD of 2 (Figure 5), indicating a (2S,3R,4S,5S,6R,10R,11S)-configuration. Therefore, the structure of 2, namely, roussoellol C, was deduced as shown.

2.2. Cytotoxic Activities of Selected Compounds

The growth inhibitory effects of the selected compounds (13) against human colonic carcinoma cell line (SW480), human promyelocytic leukemia cells (HL-60), human non-small-cell lung cancer cells (A549), breast adenocarcinoma cell line (MCF-7), and human hepatocellular carcinoma cell line (SMMC-7721) were assayed by using MTT method [32], with adriamycin as the positive control. Compounds 13 exhibited moderate antiproliferative activities against these cells with IC50 values ranging from 6.5 to 35.7 μM (Table 2). Normally, cytotoxic natural products display better activities against HL-60 than any other cancer cell lines because HL-60 cells are much sensitive in the assay. However, it is interesting that compound 2 showed significant selectivity toward MCF-7 cells with an IC50 value of 6.5 μM but with an IC50 value of 10.9 μM against HL-60. Although an IC50 value of 6.5 μM does not indicate strong potency, the selectivity of 2 against MCF-7 still makes it a promising lead compound for further studies.

3. Materials and Methods

3.1. General Experimental Procedures

Optical rotations were measured on a Rudolph Autopol IV automatic polarimeter with a 0.7 mL cell (Rudolph Research Analytical, Hackettstown, NJ, USA). UV spectra were recorded with a PerkinElmer Lambda 35 spectrophotometer (PerkinElmer, Inc., Fremont, CA, USA). IR spectra were measured on a Bruker Vertex 70 FT-IR spectrophotometer (Bruker, Karlsruhe, Germany). ECD data were obtained with a JASCO-810 instrument (JASCO Co., Ltd., Tokyo, Japan). HRESIMS data were recorded on a Thermo Fisher LTQ XL LC/MS (Thermo Fisher, Palo Alto, CA, USA). 1D and 2D NMR spectra were measured with a Bruker AM-400 NMR spectrometer at 25 °C (Bruker, Karlsruhe, Germany), the NOESY mixing time was 100 ms. Compounds were purified by an Agilent 1220 HPLC (Agilent Technologies Inc., Santa Clara, CA, USA) system semi-preparative HPLC equipped with a UV detector (Agilent Technologies Inc.). Column chromatography was performed on silica gel (100–200 and 200–300 mesh, Qingdao Marine Chemical Inc., Qingdao, China), Sephadex LH-20 (Pharmacia Biotech AB, Uppsala, Sweden) and ODS (50 μm, YMC, Kyoto, Japan).

3.2. Fungal Material

The fungus PP-414 was isolated from a mud sample collected on the coastal beach in Qinghuangdao County, Hebei Province, China. The mud sample (5 g) was suspended in 50 mL sterile water with a concentration at 10–1 g/mL and then every 0.5 mL mutterlauge was respectively diluted to 10–2, 10–3, 10–4 g/mL with sterile water. Each sample was coated individually on potato dextrose agar (PDA) medium contained chloramphenicol, and incubated at 28 °C to get single colonies by routine microbiological methods. The internal transcribed spacer (ITS) region was amplified by PCR using primers ITS1 (5′-TCCGTAGGTGAACCTGCGG-3′) and ITS4 (5′-TCCTCCGCTTATTGATATGC-3′), then submitted to GenBank and identified as Talaromyces purpurogenus by ITS sequence homology (99% similarity with Talaromyces purpurogenus strain Q2, accession no. KX432212.1 (max score 974, query cover 96%, e value 0.0)) and physiological characteristics with accession no. MH120320. The voucher sample, PP-414, has been preserved in the culture collection center of Tongji Medical College, Huazhong University of Science and Technology (Wuhan, China).

3.3. Fermentation and Isolation

The fungus PP-414 was incubated on potato dextrose agar (PDA) at 28 °C for 7 days, the agar cultures were cut into small pieces (approximately 0.5 × 0.5 × 0.5 cm3) and then inoculated into 100 × 1 L Erlenmeyer flasks which containing 250 g rice and 250 mL distilled water. After incubating at 28 °C for 28 days, the solid rice medium was distilled with CH3CH2OH and then extracted three times with EtOAc. The EtOAc extract (80 g) was chromatographed on silica gel chromatography column (CC, 80–120 mesh) eluting with petroleum ether/EtOAc (100:0–0:1, v/v) to afford five fractions (Fr. A-Fr. E). Fr. C (4.5 g) was further separated by Sephadex LH-20 (CH2Cl2/MeOH 1:1) and silica gel CC (200–300 mesh) eluting with CH2Cl2/MeOH (200:1–20:1, v/v) to obtain four fractions (C1-C5), Fr. C2 was further purified by semi-preparative HPLC (MeCN-H2O, 85:15, v/v) to yield 3 (9.0 mg, tR = 52.5 min). Fr. C3 was further purified by semi-preparative HPLC (MeCN-H2O, 45:55, v/v) to obtain 6 (6.0 mg, tR = 35.2 min). Fr. C4 was further separated by Sephadex LH-20 (MeOH) and semi-preparative HPLC (MeOH-H2O, 65:35, v/v) to yield 4 (4.5 mg, tR = 20.0 min) and 5 (5.0 mg, tR = 46.0 min).
Fr. D (8.5 g) was further separated by reversed-phase MPLC (MeOH/H2O, 10:90–100:0) to obtain seven fractions (D1–D7), Fr. D6 was purified by Sephadex LH-20 (CH2Cl2/MeOH 1:1) and silica gel CC (200–300 mesh) eluting with CH2Cl2/MeOH (200:1–10:1, v/v) to obtain four fractions (D6.1–D6.4), Fr. D6.3 was further purified by semi-preparative HPLC (MeOH-H2O, 65:35, v/v) to yield 1 (2.5 mg, tR = 16.0 min). Fr. D6.4 was further separated by semi-preparative HPLC (MeOH-H2O, 55:45, v/v) to yield 2 (1.1 mg, tR = 27.5 min).
Compound 1: pale yellow oil (MeOH), [α] D 25 + 43.0 (c 0.1, MeOH); UV (MeOH) λmax (log ε) 203 (3.71), 235 (3.51) nm; CD (MeOH) λmaxε) 203 (−1.37), 233 (2.17), 263 (0.54), 282 (0.72), 335 (−0.13) nm; IR νmax 3432, 2923, 1696, 1647, 1382, 1246, 1062 cm–1; 1H and 13C NMR data, see Table 1; HRESIMS m/z 265.1450 [M − H] (calcd. for C15H21O4, 265.1440).
Compound 2: colorless oil (MeOH), [α] D 25 − 4.0 (c 0.05, MeOH); UV (MeOH) λmax (log ε) 202 (3.87), 212 (3.81), 225 (3.84) nm; CD (MeOH) λmaxε) 212 (−7.28), 232 (−2.44), 243 (−3.34) nm; IR νmax 3430, 2928, 1742, 1631, 1384, 1218, 1027 cm–1; 1H and 13C NMR data, see Table 1; HRESIMS m/z 371.1839 [M + Na]+ (calcd. for C20H28O5Na, 371.1834).

3.4. NMR Calculation

The 13C NMR chemical shifts of each conformer were calculated at the B3LYP/6-311++G(d,p)//B3LYP/6-31G(d) level by the IEFPCM solvation model implemented using Gaussian 09 program with MeOH as solvent, which were then combined using Boltzmann weighting according to their population contributions. The detailed methods were the same as previously described [33].

3.5. ECD Calculation

The electronic circular dichroism (ECD) spectra of each conformer were calculated by the TDDFT methodology with MeOH as solvent. The detailed methods were the same as previously described [32] The ECD spectra of each conformer were simulated using a Gaussian function with a bandwidth σ of 0.4 eV. The spectra were combined after Boltzmann weighting according to their population contributions and UV correction was applied.

3.6. Cytotoxicity against Cancer Cell Lines

Cytotoxicity of the selected compounds against the five cancer cell lines (SW480, HL-60, A549, MCF-7, and SMMC-7721) was evaluated by the MTT method with adriamycin as positive control. All cells were cultured in RPMI.1640 medium contained 10% fetal bovine serum, 2 mM l-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin at 37 °C in a humidified atmosphere with 5% CO2. Tumor cells were seeded in 96-well microtiter plates at 5000 cells/wel, and the test compounds at concentrations ranging from 1.56 to 50 µM were added to the wells 12 h later. After incubation for 48 h, the metabolic conversion of 20 μL of MTT (5 mg/mL) 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide was added and the incubation was continued for 4 h at 37 °C. The medium was exchanged with the medium containing 100 μL triplex solution of 10% SDS, 5% isopropyl alcohol and 12 mM HCl and then cultured 12–20 h at 37 °C. The results were obtained using a microplate spectrophotometer plate reader at 570 nm and the value of inhibition was calculated by formula: % inhibition = [(ODcontrol − ODtreated)/ODcontrol] × 100%. Selected compounds were tested at five concentrations (50, 25, 12.5, 6.25, 3.12 and 1.56 μM) in 100% DMSO with a final concentration of DMSO was 0.5% (v/v) in each well. The IC50 values were calculated by the means ± SEM calculating by GraphPad Prism 5.

4. Conclusions

In conclusion, we have reported six metabolites, including two new structures from the culture extract of T. purpurogenus. Among them, 9,10-diolhinokiic acid (1) is the first reported thujopsene-type sesquiterpenoid containing a 9,10-diol moiety and roussoellol C (2) possesses a novel tetracyclic fusicoccane diterpenoid with an unexpected hydroxyl at C-4. This study further enriched the structure diversity of secondary metabolites of this species. Additionally, compound 2 showed significant selectivity aginst MF-7 with IC50 values of 6.5 μM, which makes it a promising lead compound for further studies.

Supplementary Materials

The following are available online at https://www.mdpi.com/1660-3397/16/5/150/s1, HR-ESI-MS, IR, UV and NMR spectra of new compounds 1 and 2, as well as computational data for compound 2.

Author Contributions

W.W. conducted the main experiments, data analyzes, and wrote the manuscript, X.W. and J.L. were responsible for the NMR and ECD calculations, J.W. conducted the fermentation of fungi, H.Z. analyzed the spectroscopic data, C.C. and Y.Z. designed the experiments and commented on the manuscript.

Funding

This work was financially supported by the Program for Changjiang Scholars of Ministry of Education of the People’s Republic of China (No. T2016088); National natural Science Foundation for Distinguished Young Scholars (No. 81725021); Innovative Research Groups of the National Natural Science Foundation of China (81721005); the Academic Frontier Youth Team of HUST; the Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College (HUST).

Acknowledgments

We thank the Analytical and Testing Center at Huazhong University of Science and Technology for assistance in testing of ECD, UV and IR analyses. We thank Chong Dai and Ying Tang for assistance in isolated experiment.

Conflicts of Interest

The authors declare no conflict of iterest.

References

  1. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 2016, 79, 629–661. [Google Scholar] [CrossRef] [PubMed]
  2. Evidente, A.; Kornienko, A.; Cimmino, A.; Andolfi, A.; Lefrance, F.; Mathieu, V.; Kiss, R. Fungal metabolites with anticancer activity. Nat. Prod. Rep. 2014, 31, 617–627. [Google Scholar] [CrossRef] [PubMed]
  3. Samson, R.A.; Yilmaz, N.; Houbraken, J.; Spierenburg, H.; Seifert, K.A.; Peterson, S.W.; Varga, J.; Frisvad, J.C. Phylogeny and nomenclature of the genus talaromyces and taxa accommodated in penicillium subgenus biverticillium. Stud. Mycol. 2011, 70, 159–183. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Centko, R.M.; Williams, D.E.; Patrick, B.O.; Akhtar, Y.; Garcia Chavez, M.A.; Wang, Y.A.; Isman, M.B.; de Silva, E.D.; Andersen, R.J. Dhilirolides E–N, meroterpenoids produced in culture by the fungus Penicillium purpurogenum collected in Sri Lanka: Structure elucidation, stable isotope feeding studies, and insecticidal activity. J. Org. Chem. 2014, 79, 3327–3335. [Google Scholar] [CrossRef] [PubMed]
  5. Silva, E.D.; Williams, D.E.; Jayanetti, D.R.; Centko, R.M.; Patrick, B.O.; Wijesundera, R.L.; Andersen, R.J. Dhilirolides A–D, meroterpenoids produced in culture by the fruit-infecting fungus Penicillium purpurogenum collected in Sri Lanka. Org. Lett. 2011, 13, 1174–1177. [Google Scholar] [CrossRef] [PubMed]
  6. Sun, J.; Zhu, Z.X.; Song, Y.L.; Ren, Y.; Dong, D.; Zheng, J.; Liu, T.; Zhao, Y.F.; Tu, P.F.; Li, J. Anti-neuroinflammatory constituents from the fungus Penicillium purpurogenum MHZ 111. Nat. Prod. Res. 2017, 31, 562–567. [Google Scholar] [CrossRef] [PubMed]
  7. Wang, H.; Wang, Y.; Wang, W.; Fu, P.; Liu, P.; Zhu, W. Anti-influenza virus polyketides from the acid-tolerant fungus Penicillium purpurogenum JS03-21. J. Nat. Prod. 2011, 74, 2014–2018. [Google Scholar] [CrossRef] [PubMed]
  8. Li, H.; Wei, J.; Pan, S.Y.; Gao, J.M.; Tian, J.M. Antifungal, phytotoxic and toxic metabolites produced by Penicillium purpurogenum. Nat. Prod. Res. 2014, 28, 2358–2361. [Google Scholar] [CrossRef] [PubMed]
  9. Xia, M.W.; Cui, C.B.; Li, C.W.; Wu, C.J.; Peng, J.X.; Li, D.H. Rare chromones from a fungal mutant of the marine-derived Penicillium purpurogenum G59. Mar. Drugs 2015, 13, 5219–5236. [Google Scholar] [CrossRef] [PubMed]
  10. Wu, C.J.; Li, C.W.; Cui, C.B. Seven new and two known lipopeptides as well as five known polyketides: The activated production of silent metabolites in a marine-derived fungus by chemical mutagenesis strategy using diethyl sulphate. Mar. Drugs 2014, 12, 1815–1838. [Google Scholar] [CrossRef] [PubMed]
  11. Xue, J.; Wu, P.; Xu, L.; Wei, X. Penicillitone, a potent in vitro anti-inflammatory and cytotoxic rearranged sterol with an unusual tetracycle core produced by Penicillium purpurogenum. Org. Lett. 2014, 16, 1518–1521. [Google Scholar] [CrossRef] [PubMed]
  12. Amagata, T.; Doi, M.; Tohgo, M.; Minoura, K.; Numata, A. Dankasterone, a new class of cytotoxic steroids produced by a Gymnascella species from a marine sponge. Chem. Commun. 1999, 30, 1321–1322. [Google Scholar] [CrossRef]
  13. Amagata, T.; Tanaka, M.; Yamada, T.; Doi, M.; Minoura, K.; Ohishi, H.; Yamori, T.; Numata, A. Variation in cytostatic constituents of a sponge-derived gymnascella dankaliensis by manipulating the carbon source. J. Nat. Prod. 2007, 70, 1731–1740. [Google Scholar] [CrossRef] [PubMed]
  14. He, F.; Sun, Y.L.; Liu, K.S.; Zhang, X.Y.; Qian, P.Y.; Wang, Y.F.; Qi, S.H. Indole alkaloids from marine-derived fungus Aspergillus sydowii SCSIO 00305. J. Antibiot. 2012, 65, 109–111. [Google Scholar] [CrossRef] [PubMed]
  15. Zhang, M.; Wang, W.L.; Fang, Y.C.; Zhu, T.J.; Gu, Q.Q.; Zhu, W.M. Cytotoxic alkaloids and antibiotic nordammarane triterpenoids from the marine-derived fungus Aspergillus sydowi. J. Nat. Prod. 2008, 71, 985–989. [Google Scholar] [CrossRef] [PubMed]
  16. Wu, G.; Liu, J.; Bi, L.; Zhao, M.; Wang, C.; Baudy-Floc’h, M.; Ju, J.; Peng, S. Toward breast cancer resistance protein (BCRP) inhibitors: Design, synthesis of a series of new simplified fumitremorgin C analogues. Tetrahedron 2007, 63, 5510–5528. [Google Scholar] [CrossRef]
  17. Matsuo, A.; Nakayama, N.; Nakayama, M. Enantiomeric type sesquiterpenoids of the liverwort Marchantia polymorpha. Phytochemistry 1985, 24, 777–781. [Google Scholar] [CrossRef]
  18. Norin, T.; Jakobsen, H.J.; Larsen, E.H.; Forsén, S.; Meisingseth, E. The chemistry of the natural order Cupressales. 49. The configuration of thujopsene. Acta Chem. Scand. 1963, 17, 738–748. [Google Scholar] [CrossRef]
  19. Górecki, M.; Jabłońska, E.; Kruszewska, A.; Suszczyńska, A.; Urbańczyklipkowska, Z.; Gerards, M.; Morzycki, J.W.; Szczepek, W.J.; Frelek, J. Practical method for the absolute configuration assignment of tert/tert 1,2-diols using their complexes with Mo2(OAc)4. J. Org. Chem. 2007, 72, 2906–2916. [Google Scholar] [CrossRef] [PubMed]
  20. Wang, W.J.; Li, D.Y.; Li, Y.C.; Hua, H.M.; Ma, E.L.; Li, Z.L. Caryophyllene sesquiterpenes from the marine-derived fungus Ascotricha sp. ZJ-M-5 by the one strain–many compounds strategy. J. Nat. Prod. 2014, 77, 1367–1371. [Google Scholar] [CrossRef] [PubMed]
  21. Takekawa, H.; Tanaka, K.; Fukushi, E.; Matsuo, K.; Nehira, T.; Hashimoto, M. Roussoellols A and B, tetracyclic fusicoccanes from Roussoella hysterioides. J. Nat. Prod. 2013, 76, 1047–1051. [Google Scholar] [CrossRef] [PubMed]
  22. White, K.N.; Amagata, T.; Oliver, A.G.; Tenney, K.; Wenzel, P.J.; Crews, P. Structure revision of spiroleucettadine, a sponge alkaloid with a bicyclic core meager in H-atoms. J. Org. Chem. 2009, 73, 8719–8722. [Google Scholar] [CrossRef] [PubMed]
  23. Rychnovsky, S.D. Predicting NMR spectra by computational methods: Structure revision of hexacyclinol. Org. Lett. 2006, 8, 2895–2898. [Google Scholar] [CrossRef] [PubMed]
  24. Zhan, G.; Zhou, J.; Liu, J.; Huang, J.; Zhang, H.; Liu, R.; Yao, G. Acetylcholinesterase inhibitory alkaloids from the whole plants of Zephyranthes carinata. J. Nat. Prod. 2017, 80, 2462–2471. [Google Scholar] [CrossRef] [PubMed]
  25. Wang, Q.X.; Bao, L.; Yang, X.L.; Liu, D.L.; Guo, H.; Dai, H.Q.; Song, F.H.; Zhang, L.X.; Guo, L.D.; Li, S.J. Ophiobolins P-T, five new cytotoxic and antibacterial sesterterpenes from the endolichenic fungus Ulocladium sp. Fitoterapia 2013, 90, 220–227. [Google Scholar] [CrossRef] [PubMed]
  26. Wei, H.; Itoh, T.; Kinoshita, M.; Nakai, Y.; Kurotaki, M.; Kobayashi, M. Cytotoxic sesterterpenes, 6-epi-ophiobolin G and 6-epi-ophiobolin N, from marine derived fungus Emericella variecolor GF10. Tetrahedron 2004, 60, 6015–6019. [Google Scholar] [CrossRef]
  27. Liu, H.B.; Edrada-Ebel, R.A.; Ebel, R.; Wang, Y.; Schulz, B.; Draeger, S.; Müller, W.E.G.; Wray, V.; Lin, W.H.; Proksch, P. Ophiobolin sesterterpenoids and pyrrolidine alkaloids from the sponge-derived fungus Aspergillus ustus. Helv. Chim. Acta 2011, 94, 623–631. [Google Scholar] [CrossRef]
  28. Zhu, T.; Lu, Z.; Fan, J.; Wang, L.; Zhu, G.; Wang, Y.; Li, X.; Hong, K.; Piyachaturawat, P.; Chairoungdua, A. Ophiobolins from the mangrove fungus Aspergillus ustus. J. Nat. Prod. 2018, 81, 2–9. [Google Scholar] [CrossRef] [PubMed]
  29. Vainio, M.J.; Johnson, M.S. Generating conformer ensembles using a multiobjective genetic algorithm. J. Chem. Inf. Model. 2007, 47, 2462–2474. [Google Scholar] [CrossRef] [PubMed]
  30. Puranen, J.S.; Vainio, M.J.; Johnson, M.S. Accurate conformation-dependent molecular electrostatic potentials for high-throughput in silico drug discovery. J. Comput. Chem. 2010, 31, 1722–1732. [Google Scholar] [CrossRef] [PubMed]
  31. Frisch, M.J.; Trucks, G.W.; Schlegel, H.B.; Scuseria, G.E.; Robb, M.A.; Cheeseman, J.R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G.A.; et al. Gaussian 09, Revision D.01, Gaussian, Inc.: Wallingford, CT, USA, 2009.
  32. Qiao, Y.; Xu, Q.; Hu, Z.; Li, X.N.; Xiang, M.; Liu, J.; Huang, J.; Zhu, H.; Wang, J.; Luo, Z.; et al. Diterpenoids of the cassane type from Caesalpinia decapetala. J. Nat. Prod. 2016, 79, 3134–3142. [Google Scholar] [CrossRef] [PubMed]
  33. Zhan, G.; Liu, J.; Zhou, J.; Sun, B.; Aisa, H.A.; Yao, G. Amaryllidaceae alkaloids with new framework types from Zephyranthes candida as potent acetylcholinesterase inhibitors. Eur. J. Med. Chem. 2017, 127, 771–780. [Google Scholar] [CrossRef] [PubMed]
Figure 1. The structures of compounds 16.
Figure 1. The structures of compounds 16.
Marinedrugs 16 00150 g001
Figure 2. Key 2D correlations of compounds 1 and 2.
Figure 2. Key 2D correlations of compounds 1 and 2.
Marinedrugs 16 00150 g002
Figure 3. Conformation of the Mo24+ complex of compound 1 and its IECD spectrum in DMSO.
Figure 3. Conformation of the Mo24+ complex of compound 1 and its IECD spectrum in DMSO.
Marinedrugs 16 00150 g003
Figure 4. Structures and differences in ppm between calculated and experimental 13C NMR shifts for 2a and 2b.
Figure 4. Structures and differences in ppm between calculated and experimental 13C NMR shifts for 2a and 2b.
Marinedrugs 16 00150 g004
Figure 5. Experimental and calculated ECD spectra of 2.
Figure 5. Experimental and calculated ECD spectra of 2.
Marinedrugs 16 00150 g005
Table 1. 1H (400 MHz) and 13C NMR (100 MHz) Data for Compound 1 and 2 (CD3OD) and DFT Calculation of 13C NMR for 2a and 2b.
Table 1. 1H (400 MHz) and 13C NMR (100 MHz) Data for Compound 1 and 2 (CD3OD) and DFT Calculation of 13C NMR for 2a and 2b.
Position122a2b
δH (J in Hz)δCδH (J in Hz)δCδC (calcd.)δC (cor)δC (calcd.)δC (cor)
1-35.71.60, d, 13.0 1.40, dd, 14.6, 13.037.639.235.936.233.7
20.85, dd, 9.1,5.011.32.70, m41.245.742.138.636.0
0.76, d, 5.1
32.11, dd, 9.0, 5.117.92.45, m40.849.645.958.755.1
4-134.33.81, d, 4.480.086.080.785.480.6
56.56, d, 4.6133.7-114.1118.4111.7115.2109.0
61.88, dd, 18.3, 2.642.83.42, br d, 9.452.857.953.855.452.0
1.78, dd, 18.3, 7.0
7-31.9-130.5133.5126.2133.7126.7
81.57, dd, 14.4, 3.141.57.04, m141.6156.4148.1148.6140.9
1.50, dd, 14.4, 3.7
94.03, ddd, 3.8, 3.7, 3.172.82.65, overlap 2.36, m28.631.428.531.028.7
103.23, d, 3.878.63.19, dd, 13.6, 2.847.951.948.150.046.8
11-39.9-46.953.249.351.648.3
12-171.22.28, dd, 15.1, 4.2 1.76, dd, 15.1, 2.645.546.643.048.245.9
131.44, s30.65.31, br s122.1128.4121.3127.8121.0
140.78, s25.9-148.4159.3150.9159.3151.1
151.31, s23.52.22, ddq, 7.9, 5.3, 7.436.741.638.240.838.1
16 0.93, d, 7.411.015.012.817.015.4
17 -173.0178.6169.4184.9175.5
18 0.84, s24.925.022.425.023.0
19 1.04, d, 6.817.717.715.417.515.8
20 3.66, dd, 10.6, 5.3 3.37, dd, 10.6, 7.967.068.964.469.665.5
Table 2. Cytotoxicities against Tumor Cells for 13 (IC50, μM).
Table 2. Cytotoxicities against Tumor Cells for 13 (IC50, μM).
123Adriamycin
SW480>4023.614.21.2
HL-6012.610.97.90.05
A54935.725.821.30.10
MCF-7>406.523.80.80
SMMC-7721>40>40>400.2

Share and Cite

MDPI and ACS Style

Wang, W.; Wan, X.; Liu, J.; Wang, J.; Zhu, H.; Chen, C.; Zhang, Y. Two New Terpenoids from Talaromyces purpurogenus. Mar. Drugs 2018, 16, 150. https://doi.org/10.3390/md16050150

AMA Style

Wang W, Wan X, Liu J, Wang J, Zhu H, Chen C, Zhang Y. Two New Terpenoids from Talaromyces purpurogenus. Marine Drugs. 2018; 16(5):150. https://doi.org/10.3390/md16050150

Chicago/Turabian Style

Wang, Wenjing, Xiao Wan, Junjun Liu, Jianping Wang, Hucheng Zhu, Chunmei Chen, and Yonghui Zhang. 2018. "Two New Terpenoids from Talaromyces purpurogenus" Marine Drugs 16, no. 5: 150. https://doi.org/10.3390/md16050150

APA Style

Wang, W., Wan, X., Liu, J., Wang, J., Zhu, H., Chen, C., & Zhang, Y. (2018). Two New Terpenoids from Talaromyces purpurogenus. Marine Drugs, 16(5), 150. https://doi.org/10.3390/md16050150

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop